65,437 trials
Chest Pain · Anxiety · Mindfulness
Primary: Mean Difference in Generalized Anxiety Disorder -7 (GAD-7) — 5.3; 3.2 score on a scale — p=0.82
Amputation; Traumatic, Hand
Primary: Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) — 74.6 scores on a scale
Telemedicine
Primary: Patient Preoperative Preparedness — 63.0; 62.5 units on a scale
Ventilation Therapy; Complications
Primary: Number of Patients With Successful Ventilation — 127; 115 Participants
Pediatric Post-operative Time to Return to Full Activity
Primary: Post Operative Outcomes - Clinical Complications — 2; 5 Participants
Knee Arthropathy
Primary: Numeric Rating Scale (NRS) Pain Scores — 5.0; 1.7 score on a scale
Ankylosing Spondylitis
Primary: Percentage of Participants Who Achieved an ASAS40 (Assessment of SpondyloArthritis International Society Criteria) — 40.85; 22.94 percentage of participants — p=<0.0001
Fragile X Syndrome (FXS)
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAE) — 0; 0; 0; 1 participants
Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Primary Mediastinal Large B-Cell Lymphoma · Refractory Diffuse Large B-Cell Lymphoma
Primary: Objective Response Rate — 3 Participants
Pulmonary Disease, Chronic Obstructive
Primary: Mean Variability in Peak Inspiratory Flow (PIF) — 67.6 Liters/minute
Mantle Cell Lymphoma
Primary: Complete Response (CR) Rate at End of Induction — 28; 4; 0; 0 Participants
Breast Cancer
Primary: Mammographic Density (Baseline) — 29.21; 28.24 percentage of glandular tissue in breast
Neuroborreliosis, Borrelia Burgdorferi
Primary: Difference in Composite Clinical Score From Inclusion to Six Months After Ended Treatment — 6.4; 6.4 units on a scale
Amputation; Traumatic, Hand
Primary: Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) — 90.3 score on a scale
Chronic Urticaria
Primary: Change in Urticaria Control Test (UCT) Score From Baseline to Week 22 in the Main Study Phase — 6.5; 3.4; 11.1; 4.8 Score on a scale